Navigation Links
Singapore Technology Incubator Receives Investment from Silicon Valley "Super-Angel"
Date:8/13/2011

and in expanding its incubation team and support infrastructure.

Clearbridge Accelerator Incubatees

The current incubatees under Clearbridge Accelerator are:

  1. Clearbridge BioMedics (www.clearbridgebiomedics.com) -- This is a National University of Singapore (NUS) spin-off company that is developing a breakthrough, non-invasive and label free oncology diagnostic platform. This involves a microfiltration system, which is able to isolate circulating tumour cells (CTCs) from just 1ml of blood. Known as the CTChip®, this could play a key role in helping clinicians to detect patient's cancer, diagnose the type of cancer and decide on the optimal, personalised oncology treatment. The CTChip® is currently undergoing clinical trials with the National Cancer Centre Singapore, as well as leading research institutions locally and in the U.S. and U.K.
  2. Clearbridge BioLoc (www.clearbridgebioloc.com) -- The company is developing a novel and cost-effective analytical system, which allows small quantities of biological samples to be rapidly processed remotely. Known as AssayQuest™, Clearbridge BioLoc's product is a fully automated analytical system that can potentially perform standard immunoassay tests from a finger-prick blood sample. This invention allows the injection and incubation of self-contained reagents, to generate results on a highly customizable blister format. Using this elegant, inventive blister pack/roller pump technology, the lab-on-a-card together with a simple roller-based reader will potentially allow any standard blood test to be customized and performed in the field. The first generation of AssayQuest™ is targeted to be launched within the next month.
  3. Clearbridge Nanom
    '/>"/>

SOURCE Clearbridge Accelerator Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology news :

1. Singapore Technology Incubator Receives Investment from Silicon Valley "Super-Angel"
2. X-SAT beams images back to Singapore
3. Singapores first locally made satellite launched into space
4. International experts to converge in Singapore for second Keystone Symposia Conference on Biofuels
5. WHO Fracture Risk Assessment Tool (FRAX) newly released for Singapore
6. Singapore scientists first to perform genome-wide study of human stem cells
7. Singapore hosts first Decade of the Mind conference in Asia
8. Clinical management of osteoporosis to be focus of Singapore meeting
9. NTU gets GreenLite for Singapores first truly eco-friendly bus
10. Singapore scientists exploit knowledge of p53 for increasing specificity of cancer treatments
11. Singapore program to provide clinical insight; showcase for regional research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ) ... Market in Japan 2014-2018" report to their ... The integration of biometrics and smart ... upgradation of the driver,s license is one of ... the aforementioned projects, biometrics is being used as ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a ... announced that its DigitalPersona ® Pro Enterprise ... have been deployed throughout First Bank branch locations ... South Carolina and Virginia. First Bank, ... Southern Pines, North Carolina , selected ...
(Date:11/21/2014)... -- Earlier this year Donald Spector , Chairman of ... the most prolific inventors in the world, got a ... to third party agencies. Spector envisioned this technology even ... earliest known patents in this area. Now major technology ... care, elder care and hospital applications. This technology has ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... inferences about the intentions of other individuals in order ... of everyday life that we humans take for granted. ... Max Planck Institute in Germany, this ability is present ... in the April issue of Current Directions in Psychological ...
... the National Institute on Drug Abuse (NIDA), part of ... time identified genes that might increase a person’s ability ... by Dr. George Uhl at NIDA’s Intramural Research Program ... the Center for Nicotine and Smoking Cessation Research at ...
... international team of 19 researchers calls for better forecasting ... The researchers, led by Daniel B. Botkin, note that ... be at risk from global warming, surprisingly few species ... period encompassing several ice ages. They suggest that this ...
Cached Biology News:Man's best friend lends insight into human evolution 2NIDA study identifies genes that might help some people abstain from smoking 2
(Date:12/17/2014)... , Dec. 17, 2014   Synageva BioPharma ... company developing therapeutic products for rare disorders, announced today ... being held in San Francisco, CA. ... and Chief Executive Officer, will present on Monday, January ... The presentation will be webcast live and may be ...
(Date:12/15/2014)... 2014 Organovo Holdings, Inc. (NYSE MKT: ... delivering breakthrough 3D bioprinting technology,  today celebrated continued ... its exVive3D TM Human Liver Tissue.  The ... commercial release on November 18, has been recognized ... awards for innovation. Most recently, on ...
(Date:12/15/2014)... Dec. 15, 2014  Ascendis Pharma A/S, a ... to address significant unmet medical needs, today announced ... 2 pediatric study to evaluate once-weekly TransCon Growth ... GHD.  This interim analysis consists of 25 patients, ... in the study, completing all six months of ...
(Date:12/13/2014)... 12, 2014 Clarassance, a privately held ... new name: Therabron Therapeutics , Inc. The new ... (a type of structure in the lungs similar to ... to develop novel protein therapeutics for the treatment of ... to change the name to mark the company's escalation ...
Breaking Biology Technology:Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... The 2nd Aesthetic Plastic Surgery and Anti Aging Medicine: The ... in New York on June 10-12, 2011. This three day ... medicine, the science of stem cells, and fat grafting applications ... plastic surgeons Drs. Sydney Coleman and J. Peter Rubin, among ...
... American Regent is conducting a nationwide voluntary recall ... mL Single Dose VialsNDC # 0517-4901-25;andDexamethasone Sodium Phosphate Injection, ... Sodium Phosphate Injection, 4 mg/mL, 30 mL Multiple Dose ... voluntary recall, initiated on March 16, 2011 to the ...
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Specialty ... This report analyzes the worldwide markets ... following product segments - Specialty Medical Enzymes, Polymerases, ...
Cached Biology Technology:Aesthetic Plastic Surgery and Anti Aging Medicine Symposium Features New Developments in the Science of Stem Cells and Fat Grafting 2American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 2American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 3American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 4American Regent Initiates Voluntary Nationwide Recall of Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Single Dose Vials; 5 mL and 30 mL Multiple Dose Vials 5Global Specialty Enzymes Industry 2Global Specialty Enzymes Industry 3Global Specialty Enzymes Industry 4Global Specialty Enzymes Industry 5Global Specialty Enzymes Industry 6Global Specialty Enzymes Industry 7Global Specialty Enzymes Industry 8Global Specialty Enzymes Industry 9Global Specialty Enzymes Industry 10Global Specialty Enzymes Industry 11Global Specialty Enzymes Industry 12Global Specialty Enzymes Industry 13Global Specialty Enzymes Industry 14Global Specialty Enzymes Industry 15Global Specialty Enzymes Industry 16Global Specialty Enzymes Industry 17Global Specialty Enzymes Industry 18Global Specialty Enzymes Industry 19Global Specialty Enzymes Industry 20Global Specialty Enzymes Industry 21Global Specialty Enzymes Industry 22Global Specialty Enzymes Industry 23Global Specialty Enzymes Industry 24
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Antibodies were affinity purified using epitopes specific to QKI immobilized on solid support....
Direct ELISA Assay Diluent, 10 L...
SpectroQuest single beam 1.8nm UV/Vis spectrophotometer; stand-alone unit...
Biology Products: